DouglasJHarrisonMD
Pediatric Hematology & Oncology • Houston, TXProfessor of Pediatrics University of Texas MD Anderson Cancer Center
Dr. Harrison is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161Fax+1 401-444-3872
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 2003 - 2006- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2000 - 2003
Rutgers New Jersey Medical SchoolClass of 2000
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2024 - 2027
OK State Medical License 2020 - 2026
TN State Medical License 2024 - 2026
WA State Medical License 2024 - 2026
AL State Medical License 2024 - 2025
GA State Medical License 2024 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
- Join now to see all
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma Start of enrollment: 2000 Nov 06
- Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Publications & Presentations
PubMed
- 2 citationsNeuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Rochelle Bagatell, Julie R Park, Sahaja Acharya, Jennifer Aldrink, Jenna Allison
Journal of the National Comprehensive Cancer Network. 2024-08-01 - 2 citationsEvent-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group.Jonathan Metts, Wei Xue, Zhengya Gao, Sapna Oberoi, Aaron R Weiss
Pediatric Blood & Cancer. 2024-07-01 - 4 citationsAddition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase...Abha A Gupta, Wei Xue, Douglas J Harrison, Douglas S Hawkins, Roshni Dasgupta
The Lancet. Oncology. 2024-07-01
Press Mentions
Michael Frumovitz, M.D., Posthumously Honored with Julie and Ben Rogers Award for ExcellenceSeptember 27th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
